Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative medicines.
The company was founded in 1987 on the discovery of a hormone, amylin, produced by the same
beta cells of the pancreas that make insulin. Since then, Amylin has built a strong foundation
on research and development. Amylin's scientists are primarily focused on investigating the
potential utility of new peptide hormone candidates. The company has amassed significant
research and clinical expertise in metabolic medicine including the areas of diabetes, obesity
and cardiovascular disease.
By "Challenging Science," Amylin challenges conventional thinking to create innovative
approaches to the discovery, development and commercialization of novel therapies for
metabolic diseases. Amylin's approach and dedication are rooted in the belief that they will
be "Changing Lives" for millions of people - not only with the drugs currently in late-stage
development, but also with their pipeline of future therapies.
AMYLIN .... Challenging Science. Changing Lives.
SEND YOUR RESUME TO firstname.lastname@example.org
A representative will contact you to schedule an appointment!